Randomized phase 3 response-adapted studies in adult early-stage (I-II) HL*
LYSA indicates Lymphoma Group and the Lymphoma Study Association; FIL, Fondazione Italiana Linfomi; UK NCRI, United Kingdom National Cancer Research Institute; and NA, not available.